Intensive pharmacokinetics of zidovudine 200 mg twice daily in HIV-1-infected patients weighing less than 60 kg on highly active antiretroviral therapy

J Acquir Immune Defic Syndr. 2006 Jul;42(3):387-9. doi: 10.1097/01.qai.0000221685.90681.1b.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiretroviral Therapy, Highly Active*
  • Area Under Curve
  • Drug Administration Schedule
  • HIV Infections / drug therapy*
  • Half-Life
  • Humans
  • Practice Guidelines as Topic
  • Reverse Transcriptase Inhibitors / administration & dosage
  • Reverse Transcriptase Inhibitors / pharmacokinetics*
  • Zidovudine / administration & dosage
  • Zidovudine / pharmacokinetics*

Substances

  • Reverse Transcriptase Inhibitors
  • Zidovudine